Hypomania Checklist – 32 (HCL-32)

1. Abstract

The Hypomania Checklist – 32 (HCL-32) is an internationally recognized, 32-item self-report psychometric instrument designed to identify lifetime hypomanic symptoms in individuals presenting with major depressive episodes or recurrent mood disturbances. Developed by Jules Angst and an international collaborative group in 2005, the scale addresses the pervasive clinical problem of the underdiagnosis and misdiagnosis of bipolar II disorder and broader bipolar spectrum disorders as unipolar depression. The instrument evaluates past episodes of behavioral activation, elevated mood, and risk-taking behaviors using a dichotomous response format (Yes / No) across 32 specific items. Psychometrically, the HCL-32 consistently demonstrates a two-dimensional latent structure comprising an Active/elated subscale (reflecting heightened energy, sociability, positive affect, and cognitive productivity) and a Risk-taking/irritable subscale (capturing impulsivity, interpersonal conflict, impatience, and chemical or behavioral recklessness). The instrument demonstrates high internal consistency across clinical and non-clinical populations, with Cronbach’s alpha coefficients typically ranging from .82 to .88 for the total score. A conventional screening cut-off score of 14 or higher yields optimal trade-offs between sensitivity (generally .75 to .85) and specificity (approximately .60 to .75) for differentiating bipolar spectrum conditions from unipolar major depression. Beyond the 32 checklist items, the instrument incorporates functional inquiry into symptom duration, life impact, and external reactions from relatives and peers. The HCL-32 has become a gold-standard screening scale in mood disorder research and clinical psychiatric assessment globally.

2. Keywords

Hypomania Checklist – 32, HCL-32, bipolar II disorder, bipolar spectrum, hypomania screening, Jules Angst, mood disorders, psychometrics, unipolar depression, differential diagnosis, active elated hypomania, risk-taking irritable hypomania

3. Authors

The Hypomania Checklist – 32 was created by a multinational consortium of academic psychiatrists and psychiatric epidemiologists, led by:

• Jules Angst, M.D., Ph.D.: Professor Emeritus of Psychiatry, Psychiatric Hospital of the University of Zurich (Burghölzli), Zurich, Switzerland. Widely regarded as a pioneering figure in the longitudinal epidemiology of affective disorders, the Zurich Cohort Study, and the dimensional conceptualization of the bipolar spectrum.
• Rolf Adolfsson, M.D., Ph.D.: Department of Clinical Sciences, Psychiatry, Umeå University, Umeå, Sweden.
• Franco Benazzi, M.D., Ph.D.: Outpatient Psychiatry Center, Forlì, Italy; leading researcher on outpatient bipolar II disorder, mixed depression, and psychiatric nosology.
• Alex Gamma, Ph.D.: Department of Psychiatry, Psychotherapy and Psychosomatics, University of Zurich, Zurich, Switzerland.
• Elie G. Hantouche, M.D.: Mood Center, Pitié-Salpêtrière Hospital, Paris, France; specialist in soft bipolarity and cyclothymia.
• Thomas D. Meyer, Ph.D.: Department of Psychology and Mental Health, University of Tübingen, Germany, and later UTHealth Harris County Psychiatric Center, Houston, Texas, USA.
• Per Skeppar, M.D.: Department of Psychiatry, Karolinska Institute, Stockholm, Sweden.
• Eduard Vieta, M.D., Ph.D.: Bipolar Disorders Program, Hospital Clínic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain; leading international authority on bipolar disorder neurobiology and therapeutics.
• Jan Scott, M.D., FRCPsych: Academic Psychiatry, Institute of Neuroscience, Newcastle University, United Kingdom.

4. Purpose

The primary purpose of the Hypomania Checklist – 32 (HCL-32) is to systematically identify lifetime manifestations of hypomanic states in patients presenting with depressive symptomatology, thereby facilitating the accurate differential diagnosis between unipolar major depressive disorder (MDD) and bipolar spectrum disorders (predominantly bipolar II disorder and cyclothymia). In standard clinical practice, hypomania is profoundly under-recognized. Because hypomanic episodes are characterized by subjective feelings of enhanced well-being, increased stamina, elevated creativity, and high functional output, individuals rarely seek medical attention during these phases. Instead, patients typically present for psychiatric consultation during periods of severe depression, psychomotor retardation, or suicidal despair, neglecting to disclose past periods of hypomania unless directly and thoroughly prompted.

The clinical consequences of failing to identify previous hypomanic episodes are severe. Misdiagnosing a bipolar patient with unipolar depression frequently leads to improper psychopharmacological monotherapy with antidepressant agents, which can precipitate rapid cycling, cycle acceleration, mixed states, treatment-emergent affective switches into full mania, or chronic treatment resistance. By providing a structured, patient-administered screening tool, the HCL-32 prompts patients to recall and recognize lifetime periods of high energy, altered sleep requirements, behavioral disinhibition, and cognitive acceleration that they might otherwise consider normal, ego-syntonic, or simply periods of good health.

In research settings, the HCL-32 provides an operationalized, dimensional metric to examine the genetic, neurobiological, cognitive, and longitudinal parameters of the bipolar spectrum. While categorical diagnostic systems like the DSM-5 enforce a strict 4-day minimum duration threshold for hypomania, empirical findings using the HCL-32 demonstrate that shorter periods of hypomanic activation (e.g., 1 to 3 days) share identical family history profiles, comorbidity patterns, and clinical trajectories with DSM-defined bipolar II disorder. Thus, the HCL-32 serves both as a pragmatic frontline clinical triage mechanism and as a heuristic research instrument investigating the boundary zone between unipolarity and bipolarity.

5. Psychological Construct

The HCL-32 operationalizes the psychological and behavioral construct of hypomania across a dimensional spectrum. Rather than viewing hypomania solely as a discrete pathological episode, the scale models it as a constellation of multi-systemic shifts across affective, cognitive, somatic, and behavioral domains. Factor-analytic investigations consistently demonstrate that the 32 items tap into two primary latent dimensions:

Active/Elated Hypomania

The Active/elated dimension corresponds to the classic, often ego-syntonic manifestations of positive activation, hyper-thymia, and increased vital energy. This dimension captures:

• Vigor and Somatic Activation: Decreased need for sleep without subsequent fatigue (Item 1), generalized feelings of heightened energy and physical activation (Items 2 and 10), and the subjective sensation of performing daily tasks faster and more effortlessly (Item 24).
• Expansive Affect and Self-Worth: Augmented self-confidence (Item 3), elevated and highly optimistic mood (Item 28), and enhanced work pleasure and occupational engagement (Item 4).
• Cognitive Acceleration and Creativity: Accelerated thought processes (Item 19), proliferation of novel concepts and creative endeavors (Item 12), and heightened linguistic wit, including punning and frequent joke-making (Item 20).
• Affiliative Sociability: Increased extroversion, outgoing behavior, and communication (Items 5, 15, and 18), decreased shyness or social inhibition (Item 13), and enhanced desire for exploratory travel (Item 6).

Risk-Taking/Irritable Hypomania

The Risk-taking/irritable dimension embodies the maladaptive, disruptive, and dysregulated manifestations of hypomanic states. This facet reflects:

• Impulsivity and Recklessness: Financial disinhibition manifesting as excessive or irresponsible spending (Item 8), accelerated driving and vehicular risk-taking (Item 7), and generalized risk exposure in work or personal pursuits (Item 9).
• Cognitive Disorganization and Distractibility: Inability to maintain sustained attention (Item 21), fragmented cognitive switching where thoughts jump rapidly between unrelated topics (Item 23), and overcommitment to an unmanageable number of new undertakings (Item 22).
• Affective Lability and Interpersonal Friction: Shortened temper, subjective impatience, and irritability (Item 25), leading directly to argumentative confrontations, quarrels (Item 27), and behavioral profiles that alienate, exhaust, or irritate peers, family members, and colleagues (Item 26).
• Behavioral Excess and Chemical Consumption: Disinhibited sexual motivation, flirtatious conduct, and hypersexuality (Items 16 and 17), flamboyant or extravagant stylistic changes in dress and makeup (Item 14), and increased consumption of stimulants, sedatives, alcohol, coffee, and nicotine (Items 29, 30, 31, and 32).

6. Theoretical Framework

The HCL-32 is anchored in the theoretical paradigm of the bipolar spectrum, championed by Jules Angst, Athanasios Koukopoulos, and Hagop Akiskal. This paradigm challenges the strict categorical dichotomy introduced by Emil Kraepelin and codified in neo-Kraepelinian nosologies like the DSM-III, DSM-IV, and DSM-5, which historically bifurcated affective disorders into strictly separated unipolar depressive disorders and bipolar disorders.

According to the dimensional spectrum model, mood disorders exist along a continuous gradient of polarity, cyclicity, and behavioral activation. At one end lies purely recurrent unipolar depression; at the opposite extreme lies severe bipolar I disorder marked by full psychotic mania. Between these poles resides an expansive clinical territory consisting of bipolar II disorder, cyclothymic temperament, recurrent brief hypomania, and antidepressant-associated hypomania. The theoretical foundation of the HCL-32 asserts that hypomanic traits are continuous phenomena that blend imperceptibly into premorbid hyperthymic and cyclothymic personality traits.

Furthermore, the architecture of the HCL-32 is underpinned by Gray’s Reinforcement Sensitivity Theory (RST) of personality, specifically the hypersensitivity of the Behavioral Activation System (BAS). In psychobiological models of bipolarity, hypomanic episodes represent periods of profound BAS hyper-reactivity driven by central dopaminergic and monoaminergic signaling dysregulation. During BAS hyperactivity, individuals demonstrate inflated reward-seeking behaviors, cognitive acceleration, grandiosity, and reduced behavioral inhibition. The HCL-32’s explicit focus on behavioral energy, appetitive goal-pursuit, risk-taking, and libido operationalizes these exact neuroethological constructs into quantifiable psychometric items.

7. Validity

The validity of the HCL-32 has been extensively appraised across dozens of cross-cultural validation trials covering inpatient, outpatient, and general population cohorts worldwide.

Criterion and Predictive Validity

In the original international multicenter validation trial by Angst et al. (2005), which evaluated outpatients across Zurich, Barcelona, Paris, Forlì, Umeå, and Newcastle, the HCL-32 successfully discriminated patients independently diagnosed with bipolar disorder from those with unipolar MDD. When employing the standard cut-off score of 14 points, the instrument demonstrated a sensitivity of 0.80 and a specificity of 0.61 for separating bipolar II disorder from unipolar depression. When discriminating bipolar I from unipolar depression, sensitivity reached 0.85. Subsequent independent studies (e.g., Vieta et al., 2007; Carta et al., 2006) observed that adjusting the cut-off to 12 or 13 points maximized sensitivity in non-specialized clinical settings, whereas higher cut-offs (15 to 16) were optimal for maximizing specificity in epidemiological research.

Convergent and Discriminant Validity

Convergent validity is robustly demonstrated by high correlations between the HCL-32 and other validated screening tools for bipolarity. The HCL-32 correlates strongly with the Mood Disorder Questionnaire (MDQ) (Pearson correlation coefficients typically ranging between r = .60 and r = .74). However, head-to-head comparative studies reveal that the HCL-32 possesses significantly greater diagnostic sensitivity than the MDQ for identifying bipolar II disorder (often exceeding the MDQ’s sensitivity by 15% to 20%), because the MDQ was constructed primarily to detect bipolar I presentations and imposes restrictive functional impairment criteria that hypomanic patients frequently fail to endorse. The HCL-32 demonstrates sound discriminant validity against scales measuring state anxiety (e.g., Hamilton Anxiety Rating Scale) and generalized neurotic distress, showing that its score variance is specifically driven by past expansive activation rather than non-specific psychiatric demoralization.

8. Reliability

The HCL-32 exhibits strong psychometric reliability across diverse populations, languages, and clinical settings:

• Internal Consistency: In the initial development cohort of Angst et al. (2005), the full 32-item scale yielded an overall Cronbach’s alpha of .82. Subsequent international adaptations reported comparable or higher indices: the Italian version demonstrated an alpha of .86 (Benazzi & Angst), the Spanish version reported .88 (Vieta et al., 2007), the Chinese validation by Yang et al. (2011) observed .84, and the Brazilian Portuguese translation achieved .87. The two primary subscales also maintain acceptable internal consistency, with the Active/elated subscale typically yielding alpha values between .80 and .86, and the shorter Risk-taking/irritable subscale yielding alpha values between .68 and .76.
• Test-Retest Reliability: Longitudinal stability assessments have verified that the HCL-32 maintains high test-retest reproducibility over intervals ranging from 2 weeks to 3 months. Intraclass correlation coefficients (ICC) and Pearson correlation coefficients consistently exceed r = .80, indicating that patients’ retrospective self-recollection of lifetime hypomanic behavior is structurally stable over time, even across varying state mood phases (e.g., retesting after partial remission of acute depressive symptoms).

9. Factor Analysis

Extensive exploratory factor analyses (EFA) and confirmatory factor analyses (CFA) have delineated the internal structural geometry of the HCL-32.

Original Two-Factor Model

In the seminal psychometric evaluation by Angst et al. (2005) using principal component analysis (PCA) with varimax rotation, a two-factor latent solution accounted for approximately 30% of the total variance:

• Factor 1: Active/Elated Hypomania accounted for the dominant share of variance (approx. 19.5%). Items loading highest on this factor include: Item 2 (“more energetic/active”, loading = .67), Item 10 (“physically more active”, loading = .66), Item 12 (“more ideas, more creative”, loading = .63), Item 3 (“more self-confident”, loading = .62), Item 4 (“enjoy my work more”, loading = .59), Item 11 (“plan more activities”, loading = .58), and Item 19 (“think faster”, loading = .57).
• Factor 2: Risk-Taking/Irritable Hypomania accounted for roughly 10.5% of the total variance. High-loading items include: Item 7 (“drive faster/take risks driving”, loading = .64), Item 9 (“take more risks in daily life”, loading = .61), Item 8 (“spend more money/too much money”, loading = .58), Item 27 (“get into more quarrels”, loading = .56), Item 25 (“more impatient/irritable”, loading = .55), and Item 26 (“exhausting/irritating for others”, loading = .53).

Alternative Factor Solutions

Subsequent psychometric investigations in larger, heterogeneous samples have occasionally supported 3-factor or 4-factor models. For instance, psychometric evaluations conducted in Italian, Chinese, and French populations have isolated an independent “Substance Use / Sexual Disinhibition” factor or separated “Irritability/Hostility” from pure behavioral risk-taking. Nonetheless, CFA fit statistics consistently demonstrate that a hierarchical two-factor structural model (or a bifactor model featuring a broad general hypomania dimension alongside orthogonal active and disinhibited group factors) maintains satisfactory fit indices across cross-cultural datasets (Comparative Fit Index [CFI] > .90, Tucker-Lewis Index [TLI] > .89, Root Mean Square Error of Approximation [RMSEA] < .05).

10. Instrument / Measurement Tool

• Instrument Name: Hypomania Checklist – 32 (HCL-32)
• Authors: Jules Angst, Rolf Adolfsson, Franco Benazzi, Alex Gamma, Elie Hantouche, Thomas D. Meyer, P. Skeppar, Eduard Vieta, and Jan Scott
• Year of Publication: 2005
• Administration Format: Paper-and-pencil self-report questionnaire or computer-administered digital assessment
• Target Population: Adult clinical populations presenting with depressive disorders, outpatients in primary care or psychiatric settings, and non-clinical research samples
• Number of Core Items: 32 dichotomous checklist items
• Response Scale: Dichotomous (Yes / No)
• Scoring Procedure:
  • Each “Yes” endorsement is scored as 1 point.
  • Each “No” endorsement is scored as 0 points.
  • Total score is obtained by summing all positive endorsements across items 1 through 32 (Theoretical score range: 0 to 32).
• Standard Diagnostic Cut-Off: A score of 14 or higher indicates a high likelihood of an underlying bipolar spectrum condition (bipolar II disorder or cyclothymia) and warrants comprehensive clinical diagnostic interview evaluation.
• Supplementary Diagnostic Sections:
  • Duration: Captures the typical duration of these energized states (< 1 day, 1–3 days, 4–7 days, > 1 week, > 1 month).
  • Impact on Functioning: Assesses whether the high states had a positive, negative, or neutral impact across family life, social life, work life, and leisure pursuits.
  • Reaction of Others: Queries how friends, family, and associates reacted to the changes (positively, neutrally, critically, negatively).

11. Permissions & Fee and Test Year

The Hypomania Checklist – 32 was first published in 2005 in the Journal of Affective Disorders. The instrument was developed with the express scientific intent of making a validated, accessible screening tool available to clinicians and researchers across the globe.

The HCL-32 is generally considered open access for academic, educational, non-commercial clinical, and scientific research endeavors without royalty fees. However, institutional users, pharmaceutical clinical trials, commercial vendors of diagnostic software, and publisher reproductions must respect international copyright laws held by the original publisher (Elsevier B.V.) and the primary authors. Formal permissions for commercial adaptation, electronic platform integration, or book republication can be requested through the Copyright Clearance Center (RightsLink) via Elsevier or by directly contacting the lead author (Prof. Dr. Jules Angst, Psychiatric Hospital, University of Zurich).

12. References

Below is a curated selection of peer-reviewed foundational literature documenting the development, psychometric validation, and clinical application of the HCL-32:

• Angst, J., Adolfsson, R., Benazzi, F., Gamma, A., Hantouche, E., Meyer, T. D., Skeppar, P., Vieta, E., & Scott, J. (2005). The HCL-32: Towards a self-assessment tool for hypomanic symptoms in outpatients. Journal of Affective Disorders, 88(2), 217–233. https://doi.org/10.1016/j.jad.2005.05.011
• Carta, M. G., Hardoy, M. C., Cadeddu, M., Murru, A., Campus, A., Lucca, A., Salviati, M., Angst, J., & Brieger, P. (2006). The validation of the Italian version of the Hypomania Checklist (HCL-32). Clinical Practice and Epidemiology in Mental Health, 2, Article 16. https://doi.org/10.1186/1745-0179-2-16
• Vieta, E., Sánchez-Moreno, J., Bulbena, A., Chamorro, L., Ramos, J. L., Artal, J., Pérez, F., Valle, J., Romero, E., & Angst, J. (2007). Cross validation with the Mood Disorder Questionnaire (MDQ) of an instrument for the detection of hypomania in Spanish: The 32 item Hypomania Checklist (HCL-32). Journal of Affective Disorders, 101(1–3), 43–55. https://doi.org/10.1016/j.jad.2006.10.024
• Meyer, T. D., Hammelstein, P., Nilsson, L. G., Skeppar, P., Adolfsson, R., & Angst, J. (2007). The Hypomania Checklist (HCL-32): Its reliability and validity in a Swedish community sample. Bipolar Disorders, 9(4), 410–417. https://doi.org/10.1111/j.1399-5618.2007.00494.x
• Yang, H. C., Yuan, C. M., Liu, T. B., Rong, H., Peng, H. J., Angst, J., & Xiang, Y. T. (2011). Validity of the 32-item Hypomania Checklist (HCL-32) in a clinical sample with mood disorders in China. BMC Psychiatry, 11, Article 84. https://doi.org/10.1186/1471-244X-11-84
• Forty, L., Jones, L., Jones, I., Smith, D. J., Caesar, S., Fraser, C., Gordon-Smith, K., Hyde, S., & Craddock, N. (2009). Identifying hypomanic features in major depressive disorder using the Hypomania Checklist (HCL-32). The British Journal of Psychiatry, 195(6), 548–553. https://doi.org/10.1192/bjp.bp.108.062083

13. Items of the Scale